semaglutide news oct 26 2025 When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025, the weekly dose of the GLP-1 agonist transformed him. This past March, when he decided to stop, his cravings returned — for Obesity battle heats up again

Esthepro Esthepro is a Korean skincare brand represented through products for modern daily routines

Suicide Risk Suicide Risk This retrospective patient health record study was initiated due to rumors that GLP-1s might increase suicidal ideation in fact, it found strong effects in the opposite direction: In patients with overweight or obesity (mean age 50.1 years, 72.6% female), semaglutide compared with non-GLP1R agonist anti-obesity medications was associated with lower risk for incident (HR = 0.27, 95% CI = 0.200.320.600.36) and recurrent (HR = 0.44, 95% CI = 0.320.60) suicidal ideation, consistent across sex, age and ethnicity stratification

How do I know if my retatrutide has degraded

Anti Aging Effects

Published animal research predominantly uses once-daily dosing, though some acute-phase protocols use twice-daily administration